Navicare Biotech Co., Ltd.
8472
Rank in Stocks
#25452
GOMAJI Corp., LTD is a Taiwanese enterprise that specializes in offering... GOMAJI Corp., LTD is a Taiwanese enterprise that specializes in offering digital commerce and marketing solutions. The company operates a comprehensive online platform designed to showcase information for a diverse range of vendors. This digital marketplace features details for businesses such as popular restaurant chains, specialized dining venues, wellness centers including spas and massage parlors, cinemas, and various other establishments within the food, beverage, and entertainment sectors. Founded in 1999, GOMAJI Corp., LTD maintains its headquarters in New Taipei City, Taiwan.
Share Price
$1.46
Last synced: 2026-11-10
Market Cap
$25.84M
Change (1 day)
-4.30%
Change (1 year)
-41.42%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Navicare Biotech Co., Ltd. (8472)
Category
Consumer Cyclical
Operating Margin for Navicare Biotech Co., Ltd. (8472)
Operating Margin as of November 2026 TTM: -3.97%
According to Navicare Biotech Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -3.97%. At the end of 2025 the company had an operating margin of -6.66%.
Operating Margin history for Navicare Biotech Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -3.97% | -40.39% |
| 2025 | -6.66% | -70.76% |
| 2024 | -22.78% | -1.85% |
| 2023 | -23.21% | 43.98% |
| 2022 | -16.12% | -506.05% |
| 2021 | 3.97% | -72.28% |
| 2020 | 14.32% | 69.67% |
| 2019 | 8.44% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 13.09% | -103.30% |
US
|
|
| 4.21% | -101.06% |
CN
|
|
| 21.86% | -105.51% |
IE
|
|
| 8.26% | -102.08% |
UY
|
|
| 19.77% | -104.98% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Navicare Biotech Co., Ltd.'s operating margin
What is Navicare Biotech Co., Ltd.'s operating margin?
Navicare Biotech Co., Ltd.'s operating margin is -3.97%, as of Nov 2026.
What was Navicare Biotech Co., Ltd.'s operating margin in 2025?
In 2025, Navicare Biotech Co., Ltd.'s operating margin was -6.66%, compared with -22.78% in 2024.
How has Navicare Biotech Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Navicare Biotech Co., Ltd.'s operating margin was highest in 2020 (14.32%) and lowest in 2023 (-23.21%).
How does Navicare Biotech Co., Ltd.'s operating margin compare with similar companies?
Navicare Biotech Co., Ltd.'s operating margin (-3.97%) is lower than that of all 5 similar companies listed above. The highest among them is PDD Holdings Inc., with 21.86%.